Bicycle Therapeutics Plc

Ownership Transactions Reported by 20 Insiders

Symbol: BCYC on Nasdaq
Industry: Pharmaceutical Preparations
Location: Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+1.49M	96.9%	$14.29	+$21.2M
Sells	7	-47.2K	3.1%	$20.46	-$965K
Net	-6	+1.44M	93.8%		+$20.3M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Baker Bros. Advisors Lp	Director, 10%+ Owner	$535M	+$21.2M	+4.13%	Dec 13, 2024
Kate Bingham	Director	$32.7M			Jul 13, 2021
Kevin Lee	CHIEF EXECUTIVE OFFICER, Director	$8.48M	-$362K	-4.09%	Oct 3, 2024
Gregory Paul Winter	Director	$3.16M			Jan 2, 2024
Michael Skynner	Chief Technology Officer	$2.07M	-$110K	-5.03%	Oct 3, 2024
Alistair Milnes	Chief Operating Officer	$1.56M	-$110K	-6.55%	Oct 3, 2024
Nicholas Keen	Chief Scientific Officer	$1.36M	-$80.3K	-5.59%	Jul 3, 2024
Nigel Crockett	Chief Business Officer	$1.02M	-$110K	-9.7%	Oct 3, 2024
Santiago Arroyo	Chief Development Officer	$683K			Feb 6, 2024
Dominic Smethurst	Chief Medical Officer	$642K			Jan 3, 2023
Pierre Legault	Director	$586K			Jan 2, 2024
Lee Kalowski	President and CFO	$530K			Apr 3, 2023
Michael Charles Ferguson Hannay	Chief Prod & Supply Chain Off	$499K	-$16.1K	-3.13%	Oct 3, 2024
Travis Alvin Thompson	Chief Accounting Officer	$478K	-$178K	-27.1%	Nov 11, 2024
Veronica GH Jordan	Director	$293K			Jan 2, 2024
Richard N. Kender	Director	$293K			Jan 2, 2024
Janice Bourque	Director	$293K			Jan 2, 2024
Jose-Carlos Gutierrez-Ramos	Director	$293K			Jan 2, 2024
Stephen H. Sands	Director	$210K			Feb 20, 2024
Alethia Young	Chief Financial Officer	$210K			Jan 2, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.